Loading…

Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: A prospective study

Abstract Purpose To prospectively evaluate long-term effects of repeated botulinum toxin A (BTX-A) injections in children with cerebral palsy (CP). Methods Repeated injections of BTX-A were offered to children with CP, according to clinical indications, for a maximum of four injections within a peri...

Full description

Saved in:
Bibliographic Details
Published in:Journal of children's orthopaedics 2008-02, Vol.2 (1), p.29-35
Main Authors: Fattal-Valevski, Aviva, Domenievitz, Dafna, Giladi, Nir, Wientroub, Shlomo, Hayek, Shlomo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c508t-83428a2f7cc320bce06dc27934f05207204e5203ea048b22b3180eba344dcbbc3
cites cdi_FETCH-LOGICAL-c508t-83428a2f7cc320bce06dc27934f05207204e5203ea048b22b3180eba344dcbbc3
container_end_page 35
container_issue 1
container_start_page 29
container_title Journal of children's orthopaedics
container_volume 2
creator Fattal-Valevski, Aviva
Domenievitz, Dafna
Giladi, Nir
Wientroub, Shlomo
Hayek, Shlomo
description Abstract Purpose To prospectively evaluate long-term effects of repeated botulinum toxin A (BTX-A) injections in children with cerebral palsy (CP). Methods Repeated injections of BTX-A were offered to children with CP, according to clinical indications, for a maximum of four injections within a period of two years. Injections were administered into lower extremity muscles of 26 consecutive children (age 3.7 ± 1.2 years, 16 boys) with hemiplegic or diplegic CP. Clinical assessments before and one month following each injection included a gross motor function measure (GMFM), a modified Ashworth scale, and range-of-motion of knee extension and ankle dorsiflexion. Results Twelve children received two injections, six received three injections, five received one injection, and three received four injections. The most common reason for discontinuing treatment was the need for orthopedic surgery (n = 17). A long-term effect was demonstrated by a significant increase of the GMFM score before the first injection compared with the last injection for each patient (P < 0.0001). There was no comparable change in the muscle tone or range-of-motion. The mean rate of GMFM change during the study was significantly higher than literature norms for CP children (13.2 vs. 5.37 per year, respectively, P < 0.01). The increase of the GMFM score before and one-month after injection (short-term effect) was significantly higher after the first injection than after the last injection (P < 0.05). Similar results were found for the Ashworth scale and popliteal angle. Conclusions Botulinum toxin A injections have a long-term effect on gross motor function in children with CP even though the effect on muscle tone is short-term. The effect apparently declines with repeated injections, with most children benefitting from 2 to 3 injections.
doi_str_mv 10.1007/s11832-007-0075-8
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2656782</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1007_s11832-007-0075-8</sage_id><sourcerecordid>2584549977</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-83428a2f7cc320bce06dc27934f05207204e5203ea048b22b3180eba344dcbbc3</originalsourceid><addsrcrecordid>eNqNUUtv1DAQjhCIPuAHcEGWOHBKGT-SOByQqooC0kpc4Gw5zmTXq8QOttOy_x5Hu2qBA-JgzWi-h8f-iuIVhSsK0LyLlErOytyupyrlk-KcypqXrBLy6UPP6FlxEeMeoIa2lc-LM9pykDXAeeE33m3LhGEiOAxoEvEDCTijTtgT6_Z5ZL2L67jzaRmtWyaS_E_rMkrMzo59QEfubdoRgwG7oEcy6zEe3pNrMgcf59XiDklMS394UTwbMogvT_Wy-H778dvN53Lz9dOXm-tNaSqQqZRcMKnZ0BjDGXQGoe4Na1ouBqgYNAwE5spRg5AdYx2nErDTXIjedJ3hl8WHo--8dBP2Bl3Ki6k52EmHg_Laqj8RZ3dq6-8Uq6u6kSwbvD0ZBP9jwZjUZKPBcdQO_RJVwzlnHFqRmW_-Yu79Elx-nWKVFJVo26bJLHpkmfwlMeDwsAsFtaapjmmqtV3TVDJrXv_-iEfFKb5MYEdCzJDbYni8-l-uVyeR3uL_CH4B5ji6Cw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2584549977</pqid></control><display><type>article</type><title>Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: A prospective study</title><source>Open Access: PubMed Central</source><source>SAGE Open Access</source><source>Springer Nature - SpringerLink Journals - Fully Open Access </source><source>Publicly Available Content (ProQuest)</source><creator>Fattal-Valevski, Aviva ; Domenievitz, Dafna ; Giladi, Nir ; Wientroub, Shlomo ; Hayek, Shlomo</creator><creatorcontrib>Fattal-Valevski, Aviva ; Domenievitz, Dafna ; Giladi, Nir ; Wientroub, Shlomo ; Hayek, Shlomo</creatorcontrib><description>Abstract Purpose To prospectively evaluate long-term effects of repeated botulinum toxin A (BTX-A) injections in children with cerebral palsy (CP). Methods Repeated injections of BTX-A were offered to children with CP, according to clinical indications, for a maximum of four injections within a period of two years. Injections were administered into lower extremity muscles of 26 consecutive children (age 3.7 ± 1.2 years, 16 boys) with hemiplegic or diplegic CP. Clinical assessments before and one month following each injection included a gross motor function measure (GMFM), a modified Ashworth scale, and range-of-motion of knee extension and ankle dorsiflexion. Results Twelve children received two injections, six received three injections, five received one injection, and three received four injections. The most common reason for discontinuing treatment was the need for orthopedic surgery (n = 17). A long-term effect was demonstrated by a significant increase of the GMFM score before the first injection compared with the last injection for each patient (P &lt; 0.0001). There was no comparable change in the muscle tone or range-of-motion. The mean rate of GMFM change during the study was significantly higher than literature norms for CP children (13.2 vs. 5.37 per year, respectively, P &lt; 0.01). The increase of the GMFM score before and one-month after injection (short-term effect) was significantly higher after the first injection than after the last injection (P &lt; 0.05). Similar results were found for the Ashworth scale and popliteal angle. Conclusions Botulinum toxin A injections have a long-term effect on gross motor function in children with CP even though the effect on muscle tone is short-term. The effect apparently declines with repeated injections, with most children benefitting from 2 to 3 injections.</description><identifier>ISSN: 1863-2521</identifier><identifier>EISSN: 1863-2548</identifier><identifier>DOI: 10.1007/s11832-007-0075-8</identifier><identifier>PMID: 19308600</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Ankle ; Bone surgery ; Botulinum toxin ; Cerebral palsy ; Clinical trials ; Medicine ; Medicine &amp; Public Health ; Original Clinical ; Original Clinical Article ; Orthopedics ; Patients ; Pediatrics ; Spasticity ; Traumatic Surgery</subject><ispartof>Journal of children's orthopaedics, 2008-02, Vol.2 (1), p.29-35</ispartof><rights>2008 European Pediatric Orthopaedic Society (EPOS), unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses.</rights><rights>EPOS 2008</rights><rights>2008. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-83428a2f7cc320bce06dc27934f05207204e5203ea048b22b3180eba344dcbbc3</citedby><cites>FETCH-LOGICAL-c508t-83428a2f7cc320bce06dc27934f05207204e5203ea048b22b3180eba344dcbbc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2584549977/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2584549977?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,21966,25753,27853,27924,27925,37012,37013,44590,44945,45333,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19308600$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fattal-Valevski, Aviva</creatorcontrib><creatorcontrib>Domenievitz, Dafna</creatorcontrib><creatorcontrib>Giladi, Nir</creatorcontrib><creatorcontrib>Wientroub, Shlomo</creatorcontrib><creatorcontrib>Hayek, Shlomo</creatorcontrib><title>Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: A prospective study</title><title>Journal of children's orthopaedics</title><addtitle>J Child Orthop</addtitle><addtitle>J Child Orthop</addtitle><description>Abstract Purpose To prospectively evaluate long-term effects of repeated botulinum toxin A (BTX-A) injections in children with cerebral palsy (CP). Methods Repeated injections of BTX-A were offered to children with CP, according to clinical indications, for a maximum of four injections within a period of two years. Injections were administered into lower extremity muscles of 26 consecutive children (age 3.7 ± 1.2 years, 16 boys) with hemiplegic or diplegic CP. Clinical assessments before and one month following each injection included a gross motor function measure (GMFM), a modified Ashworth scale, and range-of-motion of knee extension and ankle dorsiflexion. Results Twelve children received two injections, six received three injections, five received one injection, and three received four injections. The most common reason for discontinuing treatment was the need for orthopedic surgery (n = 17). A long-term effect was demonstrated by a significant increase of the GMFM score before the first injection compared with the last injection for each patient (P &lt; 0.0001). There was no comparable change in the muscle tone or range-of-motion. The mean rate of GMFM change during the study was significantly higher than literature norms for CP children (13.2 vs. 5.37 per year, respectively, P &lt; 0.01). The increase of the GMFM score before and one-month after injection (short-term effect) was significantly higher after the first injection than after the last injection (P &lt; 0.05). Similar results were found for the Ashworth scale and popliteal angle. Conclusions Botulinum toxin A injections have a long-term effect on gross motor function in children with CP even though the effect on muscle tone is short-term. The effect apparently declines with repeated injections, with most children benefitting from 2 to 3 injections.</description><subject>Ankle</subject><subject>Bone surgery</subject><subject>Botulinum toxin</subject><subject>Cerebral palsy</subject><subject>Clinical trials</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Original Clinical</subject><subject>Original Clinical Article</subject><subject>Orthopedics</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Spasticity</subject><subject>Traumatic Surgery</subject><issn>1863-2521</issn><issn>1863-2548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>PIMPY</sourceid><recordid>eNqNUUtv1DAQjhCIPuAHcEGWOHBKGT-SOByQqooC0kpc4Gw5zmTXq8QOttOy_x5Hu2qBA-JgzWi-h8f-iuIVhSsK0LyLlErOytyupyrlk-KcypqXrBLy6UPP6FlxEeMeoIa2lc-LM9pykDXAeeE33m3LhGEiOAxoEvEDCTijTtgT6_Z5ZL2L67jzaRmtWyaS_E_rMkrMzo59QEfubdoRgwG7oEcy6zEe3pNrMgcf59XiDklMS394UTwbMogvT_Wy-H778dvN53Lz9dOXm-tNaSqQqZRcMKnZ0BjDGXQGoe4Na1ouBqgYNAwE5spRg5AdYx2nErDTXIjedJ3hl8WHo--8dBP2Bl3Ki6k52EmHg_Laqj8RZ3dq6-8Uq6u6kSwbvD0ZBP9jwZjUZKPBcdQO_RJVwzlnHFqRmW_-Yu79Elx-nWKVFJVo26bJLHpkmfwlMeDwsAsFtaapjmmqtV3TVDJrXv_-iEfFKb5MYEdCzJDbYni8-l-uVyeR3uL_CH4B5ji6Cw</recordid><startdate>20080201</startdate><enddate>20080201</enddate><creator>Fattal-Valevski, Aviva</creator><creator>Domenievitz, Dafna</creator><creator>Giladi, Nir</creator><creator>Wientroub, Shlomo</creator><creator>Hayek, Shlomo</creator><general>SAGE Publications</general><general>Springer Berlin Heidelberg</general><general>Sage Publications Ltd</general><scope>AFRWT</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080201</creationdate><title>Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: A prospective study</title><author>Fattal-Valevski, Aviva ; Domenievitz, Dafna ; Giladi, Nir ; Wientroub, Shlomo ; Hayek, Shlomo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-83428a2f7cc320bce06dc27934f05207204e5203ea048b22b3180eba344dcbbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Ankle</topic><topic>Bone surgery</topic><topic>Botulinum toxin</topic><topic>Cerebral palsy</topic><topic>Clinical trials</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Original Clinical</topic><topic>Original Clinical Article</topic><topic>Orthopedics</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Spasticity</topic><topic>Traumatic Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fattal-Valevski, Aviva</creatorcontrib><creatorcontrib>Domenievitz, Dafna</creatorcontrib><creatorcontrib>Giladi, Nir</creatorcontrib><creatorcontrib>Wientroub, Shlomo</creatorcontrib><creatorcontrib>Hayek, Shlomo</creatorcontrib><collection>SAGE Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of children's orthopaedics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fattal-Valevski, Aviva</au><au>Domenievitz, Dafna</au><au>Giladi, Nir</au><au>Wientroub, Shlomo</au><au>Hayek, Shlomo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: A prospective study</atitle><jtitle>Journal of children's orthopaedics</jtitle><stitle>J Child Orthop</stitle><addtitle>J Child Orthop</addtitle><date>2008-02-01</date><risdate>2008</risdate><volume>2</volume><issue>1</issue><spage>29</spage><epage>35</epage><pages>29-35</pages><issn>1863-2521</issn><eissn>1863-2548</eissn><abstract>Abstract Purpose To prospectively evaluate long-term effects of repeated botulinum toxin A (BTX-A) injections in children with cerebral palsy (CP). Methods Repeated injections of BTX-A were offered to children with CP, according to clinical indications, for a maximum of four injections within a period of two years. Injections were administered into lower extremity muscles of 26 consecutive children (age 3.7 ± 1.2 years, 16 boys) with hemiplegic or diplegic CP. Clinical assessments before and one month following each injection included a gross motor function measure (GMFM), a modified Ashworth scale, and range-of-motion of knee extension and ankle dorsiflexion. Results Twelve children received two injections, six received three injections, five received one injection, and three received four injections. The most common reason for discontinuing treatment was the need for orthopedic surgery (n = 17). A long-term effect was demonstrated by a significant increase of the GMFM score before the first injection compared with the last injection for each patient (P &lt; 0.0001). There was no comparable change in the muscle tone or range-of-motion. The mean rate of GMFM change during the study was significantly higher than literature norms for CP children (13.2 vs. 5.37 per year, respectively, P &lt; 0.01). The increase of the GMFM score before and one-month after injection (short-term effect) was significantly higher after the first injection than after the last injection (P &lt; 0.05). Similar results were found for the Ashworth scale and popliteal angle. Conclusions Botulinum toxin A injections have a long-term effect on gross motor function in children with CP even though the effect on muscle tone is short-term. The effect apparently declines with repeated injections, with most children benefitting from 2 to 3 injections.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>19308600</pmid><doi>10.1007/s11832-007-0075-8</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1863-2521
ispartof Journal of children's orthopaedics, 2008-02, Vol.2 (1), p.29-35
issn 1863-2521
1863-2548
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2656782
source Open Access: PubMed Central; SAGE Open Access; Springer Nature - SpringerLink Journals - Fully Open Access ; Publicly Available Content (ProQuest)
subjects Ankle
Bone surgery
Botulinum toxin
Cerebral palsy
Clinical trials
Medicine
Medicine & Public Health
Original Clinical
Original Clinical Article
Orthopedics
Patients
Pediatrics
Spasticity
Traumatic Surgery
title Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: A prospective study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T04%3A36%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20effect%20of%20repeated%20injections%20of%20botulinum%20toxin%20in%20children%20with%20cerebral%20palsy:%20A%20prospective%20study&rft.jtitle=Journal%20of%20children's%20orthopaedics&rft.au=Fattal-Valevski,%20Aviva&rft.date=2008-02-01&rft.volume=2&rft.issue=1&rft.spage=29&rft.epage=35&rft.pages=29-35&rft.issn=1863-2521&rft.eissn=1863-2548&rft_id=info:doi/10.1007/s11832-007-0075-8&rft_dat=%3Cproquest_pubme%3E2584549977%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c508t-83428a2f7cc320bce06dc27934f05207204e5203ea048b22b3180eba344dcbbc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2584549977&rft_id=info:pmid/19308600&rft_sage_id=10.1007_s11832-007-0075-8&rfr_iscdi=true